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A human cell surface displays many complex-structured receptors for receiving extracellular signals to
regulate cellular functions. The use of precisely regulated signal-controls of the receptors could have
possibilities beyond the current synthetic biology research that begins with the transfection of exogenous
molecules to rewire intracellular circuits. However, by using a current ligand-receptor technique, the
configuration of the artificially assembled cell surfacemolecules has been undefined because the assemblage
is an unsystematic molecular clustering. Thus, the system bears improvements for precisely regulating
receptor functions. We report here a new tool that refines stereochemically-controlled positioning of an
assembled surface receptor. The tool performs rationally as anON/OFF switch and is finely tunable so that a
3 to 6 nm size difference of the device precisely distinguishes the efficiency of apoptosis induced via
cell-surface receptor binding.We discuss the potential use of the device in next-generation synthetic biology
and in cell surface studies.
E
ngineered genetic circuits have been developed to establish simple and independent control of biological
processes in synthetic biology. Lately, artificial regulations of signal transduction pathways have been
reported to control cell fate and to build biocomputing systems1. In either case, the process of synthetically
engaging the signal pathways begins with the transfection of molecules such as plasmids, RNA or antibiotics.
Meanwhile, cell-surface receptors are activated to turn on the signal transduction cascades with ligand binding,
indicating that artificially activated receptors can be used as triggers for regulating original or re-wired channels to
perform desired tasks. Thus, the use of synthetic signal controllers of receptors could have research possibilities
beyond intracellular synthetic biology.
For artificial activation of the cell surface receptors, the receptor clustering has been investigatedwith nanoscale
synthetic ligands2. In its most advanced form, multiple ligands are attached to a soluble biopolymer to yield
multivalent conjugates3. However, the relative configuration of the multivalent ligands is undefined and obscure
because they are attached to a freely mobile biopolymer whose behavior is highly elastic by nature. Therefore, the
polymer system is unsuitable for investigating the receptor complex assembly (specifically, the inter-receptor
distance, the relative configulation and the orientation of the receptors) and other atypical cell-surface receptors
that require a sophisticated structurally-ordered assembly4.
For example, a densely packed assembly is essential for the distance-dependent molecular interactions of cell-
surface receptors such as TNFR5, glycoprotein receptors6 and growth factor receptors7. These interactions regu-
late mammalian cellular functions including apoptosis, signal transduction, enzymatic reactions and cell-cell
interactions8. The receptormoleculesmust be precisely assembled to enhance themolecular interactions required
for initiating signal transduction9. Likewise, the polymer system bears improvements for precisely regulating the
cell-surface receptor function in synthetic biology.
Nucleic acids have been used as tools on the cell surface in bionanotechnology. For example, DNA nanoarrays
based on antibody-cell surface interactions have been explored for directing cell-surface interactions to position
multiple cells onto aDNA fabric10. AnRNAparticle containing folate has also been reported to specifically bind to
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antibody multimers and induce cytotoxic activity12. However, the
effectiveness of the RNA-protein complexes (RNPs), particularly
their spatial structure, to regulate physiological functions has been
unexplored. A designed RNP containing properly deployed binding
proteins for a target receptor is conceivably advantageous for the
avidity-based alignment of receptors with defined intermolecular
distances on their cell surfaces.
We report here a new RNP tool that refines stereochemically-
controlled positioning of an assembled receptor on a cell surface to
advance the cell-surface analysis. The RNP serves as an unpreced-
ented device for ON/OFF switches and fine-tuning of cell-surface
receptors to control apoptosis of a human cell. The RNP with a
designable size and shape at nano level can be customized as a
high-precision nano-device integrated into re-wired signaling net-
works in synthetic biology.
Results
Design and construction of a series of equilateral-triangular
RNPs. First, we designed RNPs composed of a series of
equilateral-triangular RNAs containing the boxC/D sequence, a
protein binding RNA motif for the L7Ae protein, in its three
apexes in silico13,14. The length of the three sides of the RNA was
altered systematically to produce a series of triangular RNPs that
insulated the attached proteins via a robust double-stranded stem
RNA. Five equilateral Tri-RNAs having 15, 26, 48, 70 and 92 bp (14,
17, 23, 29 and 34 nm by length, respectively) on each side were
prepared and termed Tri-RNA15, Tri-RNA26, Tri-RNA48, Tri-
RNA70 and Tri-RNA92, respectively (Fig. 1). Electrophoretic
mobility shift assays (EMSA) showed that the three binding motifs
in the Tri-RNAs interacted with L7Ae to produce a corresponding
shifted band (Supplementary Fig. 1a, filled arrowheads). Most of the
band corresponding to the free RNA was shifted in the presence of
4.5 timesmore amount of L7Ae. The estimated dissociation constant
between L7Ae and the box C/Dmotif was between 150 and 300 nM.
The RNPs were visualized in liquid with HS-AFM (Fig. 1,
Supplementary Fig. 1b, c). Small attachments recognized as L7Ae
were observed at the three apexes of the triangular objects (Fig. 1,
yellow arrowheads), indicating that each Tri-RNA possessed three
bound L7Ae proteins as designed. The assembly yield based on the
AFM images looks lower than that based on the EMSA because the
AFM imaging was performed in water without salt and pH adjust-
ment to avoid unacceptable noise signals to the images.
Verification of RNP binding. Next, novel Tri-RNPs were prepared
to contain multiple antibodies at the apexes. A fusion protein L7Ae-
Gb1x2, consisting of L7Ae and two antibody-binding domains in
streptococcal protein G (Gb1), was constructed to fix antibodies at
the RNA apexes by sandwiching the Fc domain of an antibody from
both sides15. The prospective binding activities of the purified L7Ae-
Gb1x2 to the RNA and anti-CD61 antibody were confirmed by
EMSA (Supplementary Fig. 2a) and western blotting analyses
(Supplementary Fig. 2b). The extent of gel-mobility shift of the
RNAs was almost the same to that with L7Ae and the RNAs
(Supplementary Fig. 1a), indicating that the binding affinity of the
L7Ae Gb1x2 is comparable to that of L7Ae by itself. As anticipated,
the HS-AFM images indicated the presence of the triangular RNA
with Gb1 next to L7Ae at the three apexes (Fig. 2a, left, open arrow-
heads) in addition to the antibody (Fig. 2a, right, arrowhead). We
next examined the avidity of the RNA-L7Ae-Gb1x2 complexes to the
cell surfaces stably expressing CD61. As expected from the in vitro
studies, the RNPs, but not the control IgG (Fig. 2b), attached to the
cell surface more effectively than the defective mutants (Supple-
mentary Fig. 2c), indicating that the three proteins on the RNA
could augment adherence to the cell surface receptors.
Size-dependent apoptosis control with designed RNPs.Dimerized
galectin-1 (Gal1) promotes the signal transduction for the apoptosis
of T cells via an assemblage of glycoreceptors that results in a
lattice structure (Fig. 3a)6,16–19. This effect indicates that multiple
Gal1s attached to the Tri-RNA can initiate signal transduction
more effectively because they can steadily hold the receptors closer
to one another on the cell surface (Fig. 3a)20–22. To assess our
hypothesis, we designed and constructed a series of Tri-RNAs with
L7Ae fused to N-terminally trimmed Gal1 (Gal1b) and that lacked
the amino acids for dimerization and pro-apoptotic activity to induce
galectin-dependent apoptosis23,24. The binding of L7Ae-Gal1b to the
RNA was confirmed by EMSA (Supplementary Fig. 3a). The EMSA
indicated that the binding affinity of L7Ae-Gal1b to RNA was
comparable to that of L7Ae. The HS-AFM image of a triangular
complex with the fusion proteins at the apexes is consistent
with the predicted structure of the Tri-RNA with L7Ae-Gal1b
Figure 1 | Illustration of Tri-RNPs used in this study and their HS-AFM images. A series of the triangular RNPs (Tri-RNA-L7Ae complexes) with the
different side lengths is displayed clockwise on white and grey rectangular tiles (left). The numbers noted represent the number of the base pairs in
each side of the Tri-RNA. The length of each Tri-RNA-L7Ae complex (Tri-RNP) is 14, 17, 23, 29, and 34 nm for Tri-RNP15, 26, 48, 70 and 92,
respectively. The widths of the rectangles are 10 nm. A purple object in the 3Dmodels represents the L7Ae protein. A blue and green represent the L- and
S-strand of the RNAs, respectively. A red is denoted as a boxC sequence in the L-strand and a yellow as a boxD sequence in the S strand. Each Tri-RNP is
assessed in HS-AFM (right). The L7Ae proteins in Tri-RNA26 are pointed with yellow arrowheads. A scale bar represents 20 nm.
www.nature.com/scientificreports
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(Tri-RNP-Gal1b) (Fig. 3b left). The time-lapse images of the
dissociation of L7Ae with another sphere (Fig. 3b right) from the
RNA indicated that the sphere was Gal1b at the apexes.
Subsequently, the series of Tri-RNP-Gal1b constructs of differing
sizes (Fig. 1a) were examined for their ability to bind to the cell. The
RNPs were mixed with the cells to quantitatively determine their
presence on the cell surfaces (Supplementary Fig. 3b). The binding
of the RNPs onto the cell surfaces was visualized by fluorescence
microscopy (Fig. 3c). The binding states of the RNPs were compar-
able with a nearly two-fold difference at 600 nM (Fig. 3d,
Supplementary Fig. 3c), suggesting the possible formation of lattice
structures with the receptors. As expected, the RNPs with the three
L7Ae binding sites adhered to the cell much more firmly than those
missing one or two sites.
The effects of the RNP series on apoptosis were examined. The
cells analyzed by flow cytometry revealed that Tri-RNP15-Gal1b,
-26-Gal1b and -48-Gal1b promoted apoptosis and that the efficiency
decreased as the size of the Tri-RNA increased (Fig. 3e, f). With
respect to the efficiency, L7Ae-Gal1b in the absence of Tri-RNAs
exhibited hardly any effect on the apoptosis (Fig. 3f L7Ae-Galb). In
addition, ten times more wildtype Gal1 has been reportedly required
to achieve an apoptotic effect comparable with that achieved by Tri-
RNP15-Gal1b21. However, the larger RNPs, Tri-RNP70-Gal1b and
-92-Gal1b, did not exhibit pro-apoptotic activity. This lack of activity
was further confirmed by varying the amount of Tri-RNP15-Gal1b
and -92-Gal1b (Supplementary Fig. 3c, d). The progression of a
nuclear shrinkage was observed with Tri-RNP15-Gal1b but not with
Tri-RNP92-Gal1b (Supplementary Fig. 4a, b). Lactose served as the
inhibitor, strongly indicating that the binding of Gal1b triggered
apoptosis (Supplementary Fig. 4c)25. Thus, a 3 to 6 nm size difference
on one side of the RNP was concluded to precisely determine the
efficiency of the signal transduction initiation. The calculated length
of each side of Tri-RNP15, 26, 48, 70 and 92 is 14, 17, 23, 29 and
34 nm, respectively (Fig. 1a). The designed smaller RNPs conceiv-
ably function as ON switches via a receptor-assemblage, which in
return determines the switching efficiency based on how closely
packed the structure of the designed RNP is. The designed RNPs
that have more closely packed Gal1b molecules at the apexes are
more efficient at signaling. This is likely the reason why Tri-
RNP15-Gal1b is the most effective.
Insulation of receptor molecules for blocking apoptosis.
Adversely, the binding of the larger RNPs, such as Tri-RNP70-
Gal1b and -92-Gal1b, could insulate the receptor molecules from
one another and prevent the neighbor effect from triggering signal
transduction (Fig. 3a, right). This phenomenon implies that larger
RNPs can function as OFF switches or limiters. To test this
hypothesis, a competition experiment employing Tri-RNA92 and
L7Ae-Gal1, was conducted under conditions where L7Ae-Gal1
promotes apoptosis in the presence of Tri-RNA26m3, which lacks
the L7Ae binding sites26. As anticipated, apoptosis was blocked
competitively in the presence of Tri-RNA92 but enhanced in the
presence of Tri-RNA15 (Fig. 4a). Another competitive experiment
was successfully performed with Tri-RNP15-Gal1b employing Tri-
RNP92-Gal1b as a competitor (Fig. 4b, c). Thus, Tri-RNA92 and Tri-
RNP92-Gal1b served as an OFF switch and a limiter, respectively
(Fig. 4a, c). This approach for spatially preventing particular
molecules from communicating on the cell surface can be useful
for specifically inhibiting targeted cellular events in both
experimental molecular biology and medicine.
Discussion
The results illustrate that the molecular design at a nanomolecular
level is effective for specifically regulating the functions of the cell-
surface receptor. As a next step, the integration of other synthetic
control system such as a chimeric receptor with intracellular control
devices will greatly enhances the current synthetic ligand-receptor
activation system. The intracellular domain of the chimeric receptor
enables the precise targeting of a downstream molecule whereas the
extracellular domain provides the targeting of a specific ligand part-
ner27,28. Our RNP-based ligand device could provide more sophist-
icated controls of the receptor assembly to activate or attenuate the
signal initiation. This artificial receptor-ligand system has a potential
to significantly minimize the undesired crosstalks with other signal-
ing molecules and function as an orthogonal switch which may
eventually extend to amore complex extra- and intracellular network
in synthetic biology29. Furthermore, since our device allows to tune
Figure 2 | Binding of Tri-RNA-L7Ae-Gb1x2-anti-CD61 antibody complexes to the cell surface. (a), The Tri-RNP48 complexes were visualized in
the presence (right) or the absence (left) of the anti-CD61 antibody (purple) by HS-AFM. The objects marked by the open and filled arrowheads indicate
the Gb1 domains and antibodies, respectively. The 3D models of the observed complexes are shown under the HS-AFM images. Scale bars represent
50 nm. (b), The 293 cells stably expressing the CD61 antigen are incubated with the anti-CD61 antibodies (top) or control IgG (bottom) followed by
wash, Tri-RNP (Tri-RNA-L7Ae-Gb1x2 prepared by mixing the 10 nM of the RNA and 30 nM of the protein) treatment and the fluorescent
microscopic analysis. A red and green indicate the Tri-RNAmodified by Alexa 647 and the AzamiGreen fluorescent protein, respectively. The control IgG
is a mouse IgG2a provided by MBL that does not bind the CD61 antigen. A scale bar represents 200 mm.
www.nature.com/scientificreports
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Figure 3 | Pro-apoptotic activities of Tri-RNA-L7Ae-Gal1b. (a), Illustration of apoptosis regulation by manipulating the distances between the receptor
components with small and large Tri-RNPs. The receptor components are distributed over the cell surface in the absence of the Tri-RNPs (upper). In the
presence of the Tri-RNPs, Gal1bs at each apex in the Tri-RNPs bind to the receptor components and form lattice structures. Small Tri-RNPs gather the
receptor components and form the closely packed lattice structure, resulting in apoptosis (lower left). Large Tri-RNPs adversely form the widely spaced
lattice structure and inhibit the apoptosis signal (lower right). (b), The HS-AFM image of Tri-RNP48-Gal1b (left) and time lapse images capturing the
separation of the L7Ae-Gal1b fusion protein from Tri-RNA48 (right). L7Ae and Gal1b domains are pointed by the filled purple and green arrowheads,
respectively. Scale bars represent 50 nm. (c), Fluorescentmicroscopic images of the Jurkat cells after 30 min incubation with 600 nMof the indicated Tri-
RNP and Tri-RNA. RNA is stainedwith Propidium Iodide (PI) in red andDNAwithHoechst 33342 in blue. A scale bar represents 20 mm. (d), The panel c
is quantified and graphed for the indicated Tri-RNPs. The PI intensities are measured in areas 14 pixels within the nuclear envelope excluding the nuclei.
The background intensities were subtracted by rolling ball background subtraction algorithm. The error bars are the standard deviation obtained from
analyzing 100-3,000 cells. (e), Flowcytometric analysis of the Jurkat cells after 6 hours of incubation with 600 nM of the indicated Tri-RNPs. The cells
were stained with annexin-V conjugated with Pacific Blue for the apoptotic cells. The distribution of the cells was graphed according to the Pacific Blue
intensities. The cell population between two broken lines was defined as dead cells. The graph represents one of the three independent experiments. (f),
The panel e was quantified and graphed for the indicated Tri-RNPs and controls. The error bars are the standard deviation obtained from the three
independent experiments.
www.nature.com/scientificreports
SCIENTIFIC REPORTS | 4 : 6422 | DOI: 10.1038/srep06422 4
the signal strength based on the distance between the receptors, it is
anticipated that expansion of our device by combining with an
internal control system will serve as the independent model to study
and rewire the complex cell signaling network30.
We anticipate that this class of nanotechnology provides a feasible
and rational approach for manipulating a variety of functional mole-
cules on the human cell surface. The advanced triangular (or other
polygonal) RNAs with multiple heterogeneous ligands at the tips
enhance or block the assemblage of a variety of heterogeneous cell
surface molecules with high precision on a single cell or inter-cellu-
larly. Specifically, the RNP has the potential to block the assemblage
of not only receptors but also other cell surface molecules to induce
or prevent targeted cellular events with high degree of accuracy.
The design and use of RNPs opens a new route toward the rational
design of bio-nanotechnology devices for the mammalian cell sur-
face. The device controls specific cellular events by regulating the
chemical affinity, binding specificity, physical organization and sig-
naling control of target molecules. In addition, the materials includ-
ing DNA, PNA and a number of natural and artificial organic (and
inorganic) molecules with specific structures and functions can be
incorporated easily to artificially evolve the device.
Methods
RNA preparation. All DNA templates and primers used for transcription were
purchased fromHokkaido System Science and Gene Design. For Tri-RNA15, a single
stranded template was annealed with the T7 primer and transcribed with
MEGAShortscriptTM T7 kit (life technologies) and home-made T7 RNA polymerase.
The templates for other longer RNAs were prepared by elongation of hybridized
oligonucleotides or PCR with KOD polymerase (TOYOBO) and transcribed as
described above. All the transcribed RNAs were gel-purified in denaturing
polyacrylamide gels (PAGE). Purified RNAs were dissolved in pure water and stored
at 220uC. Concentrations of RNAs and DNAs were determined by ND-1000
(Thermo scientific). Alexa 647-labeled RNAs are made by UlysisTM Alexa FluorH 647





Figure 4 | Inhibition of apoptosis by the large Tri-RNP. (a), The Jurkat cells weremixed with the L7Ae-Gal1 in the presence of the indicated Tri-RNAs. A
buffer control does not contain L7Ae-Gal1 or RNA. Following the 6 hours of incubation, the dead cells are counted by flowcytometry and bar-graphed.
The error bars represent the standard deviation obtained from three independent experiments. (b), Following 6 hours of incubation with Tri-RNA15-
L7Ae-Gal1b at the indicated concentrations in the presence (1) or absence (2) of 600 nM of Tri-RNA92-L7Ae-Gal1b, the Jurkat cells were stained with
annexin-V and counted by flowcytometry. The distribution of the cells was graphed according to the Pacific Blue intensities. The cell population between
two broken lines was defined as dead cells. The graph represents one of two independent experiments. (c), The panel b is quantified and bar-graphed. The
open and filled bars indicate the presence and absence of the 600 nM of Tri-RNP92-L7Ae-Gal1b, respectively. The error bars are the standard deviation
obtained from two or more independent experiments.
www.nature.com/scientificreports





















































































Electrophoretic gel-mobility shift assay (EMSA). The L strands and S strands of
RNAs were mixed and incubated at 80uC for 5 min in L7Ae buffer (20 mM HEPES-
KOH (pH 7.4), 150 mM KCl, 1.5 mM MgCl2) followed by the incubation at room
temperature for 10 min. The annealed RNA (100 nM) was mixed with the indicated
concentrations of the proteins. After the incubation at room temperature for 30 min,
the RNA products with a loading dye were loaded onto acrylamide gel with 0.53TBE
buffer at room temperature. After electrophoresis, the gels were stained with SYBRH
Green I/II (Lonza) and analyzed by FLA7000 (GE Healthcare).
Expression and purification of recombinant proteins. The total RNA of HeLa cells
was purified by RNAqueousH-4PCR kit (Roche). Reverse transcription of the total
RNA was performed by High Capacity cDNA Reverse Transcription Kit (Applied
Biosystems). The galectin-1 open reading frames (Gal1 and Gal1b) were amplified by
PCR using the primers 59-TATGAGATCTGTCAAAGGCCACACATTTG-39 and
59-GACACCATGGGATCCGCTTGTGGTCTGGTCGCCAG-39 for Gal1 (and 59-
GACACCATGGGATCCAGCAACCTGAATCTCAAACC-39 for Gal1b). The PCR
products were digested by NcoI and BglII and inserted into the cloning vector. After
validation of the sequences of the genes, the digested fragments were introduced into
the downstream to the L7Ae gene to generate the pET28b(1) expression vectors for
the fusion proteins, L7Ae-Gal1 and L7Ae-Gal1b. Both of them contain the amino
acids linker, R(SGG)8RS, between L7Ae and galectin-1. One-STrEP-tag and
Histidine-tag are located at the N- and C terminus of the expressed proteins,
respectively. These expression vectors were transformed into the Escherichia coli
strain BL21(DE3). Protein expression was induced at an OD660 of 0.6–0.9 by the
addition of IPTG at the final concentration of 1 mM. After 8 hours of incubation at
30uCwith shaking, the cells were harvested. The pellets were sonicated and the lysates
were centrifuged at 20,000 3 g for 30 min at 4uC to remove bacterial debris. The
supernatant was passed through a 0.22 mm filter and loaded on 1 mLHisTrap Nickel
affinity column by AKTA explorer 10S (GE Healthcare). After washing step, a pulse
injection of 150–200 mM of NaOH into the column was performed to remove RNAs
non-specifically bound to the proteins and the column. The bound protein was eluted
off of the column by the gradient concentrations of imidazole and the fraction
enriched in the target protein was determined by SDS-PAGE and Coomassie Brilliant
Blue (CBB) staining. Purified proteins were concentrated and dialyzed against the
storage buffer (50% glycerol, 14 mM of b-mercaptoethanol in PBS) and the
concentration was determined by the absorbance at 280 nm. The proteins were
stored at 220uC until used.
High Speed-Atomic force microscopy (HS-AFM). The RNA was incubated at 80uC
for 5 min and then at room temperature for 10 min in L7Ae buffer. The indicated
RNA and proteins were mixed at 25 and 250 nM in L7Ae buffer, respectively, and
incubated at room temperature for 10 min. The mixtures were dropped on a mica
surface and incubated for 5 to 10 min. The samples on the mica were scanned in
Milli-Q water by HS-AFM (NanoExplorer, Research Institute of Biomolecule
Metrology, RIBM). HS-AFM images were corrected for the background subtraction,
followed by the automatic optimization of contrast and brightness by ImageJ
software31.
Cell culture and treatments. Jurkat cells were cultured at 37uC in 5% CO2 in RPMI
1640 supplemented with 10% FBS (MP Biosceience). 293 cells were cultured at 37uC
in 5% CO2 in DMEM/F-12 supplemented with antibiotics solution (A5955, Sigma-
Aldrich) and 10% FBS. The CD61-expressing 293 cell was established as follows. 293
cells transfected with a pDIA-CD61 vector which carries an IRES-Azami Green
fluorescnence protein, were provided byMBL. The cells were cultured under the same
conditions as the 293 cells except for 500–1,000 mg/mL of G418 added to select the
stable cell line. After three-time passages, single Azami Green positive cells were
sorted into a 384well culture plate by Fluorescence-Activated Cell Sorting, FACSAria
(BD bioscience). Clones with the high Azami Green fluorescence were then selected.
The expression of the CD61 was confirmed by immunofluorescence staining with the
anti-CD61 antibody (primary) and phycoerythrin-conjugated anti-mouse IgG
(secondary) followed by FACS.
Avidity assays of antibody-containing Tri-RNPs on the 293 cells. The CD61-
expressing 293 cells were plated into a 96 well plate with 43104 cells per well. After 1
day incubation, the cells were incubated in 50 mL of the solution containing the anti-
CD61 antibody or the control mouse IgG2a 6H3H11 provided by MBL at 37uC for
1 hour and washed with OptiMEM (life technologies) twice. 30 nM of L7Ae-Gb1x2
and 10 nM of alexa 647-labeled Tri-RNAs were mixed and added to each well. After
the 1 hour of incubation, the cells were washed with OptiMEM twice to remove
remaining RNAs and L7Ae-Gb1x2 and observed on RS-100 imager (Olympus), an
automated cell imaging instrument, by a 627 nm LED and a 705/35 nm filter for
excitation and emission, respectively.
Flowcytometry analysis of apoptosis by galectin-1-conjugated RNPs. The RNPs
were preparedwith the indicated protein and RNA as in the EMSA section except that
OptiMEM was used instead of L7Ae buffer. For the experiment using lactose as a
blocking agent for galectin-1 binding, lactose dissolved inOptiMEMwas added to the
RNA solutions at a final concentration of 30 mM. The annealed RNAwasmixed with
six times more amount of the L7Ae-Gal1 or L7Ae-Gal1b gently. 50 mL of the RNP
www.nature.com/scientificreports
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solutions were transferred to 96 well plates and incubated at 37uC for more than
30 min. For the competition assays between Tri-RNP15 and 92, each RNP was
separately prepared andmixed together in a 96 well plate. After the incubation, 50 mL
of Jurkat cells washed by OptiMEM twice were added to the RNP solutions (final
concentration of 13106 cells/mL) and shaken for 10 sec on a microshaker (M-BR-
024, TAITEC) gently. After 6 hours at 37uC, lactose (final concentration of 0.1 M)
was added and the cell-clumps were carefully pippetted up and down to dissociate the
galectins. The apoptotic and dead cells were stained by Pacific BlueTM Annexin
V/SYTOXH AADvancedTM Apoptosis Kit (Invitrogen) according to the
manufacturer’s instructions. The stained cells were analyzed on FACS Aria (BD
Bioscience). A 405 nm laser was used for excitation of the Pacific blue and 488 nm for
the AADvanced dye. The 450/40 and 616/23 nm filter were used for collection of the
emission. Collected data were analyzed by R32 with flowViz and flowCore packages33.
Quantification of the RNPs bound to the Jurkat cell surface. The RNP solutions
were prepared with the indicated protein and RNA in the same way as the
flowcytometry analysis section. Jurkat cells were stained in the culture medium
supplemented with 10 mg/mL of Hoechst 33342 for 30 min followed by wash twice.
The stained cells were re-suspended in OptiMEM supplemented with 20 mg/mL of
Propidium Iodide, PI. 50 mL of the cell suspension were added into the 50 mL of RNP
solutions in a 96 well plate andmixed for 10 sec on amicroshaker. After incubation of
30 min at 37uC, the medium was replaced with fresh OptiMEM carefully. The
nucleus and RNAs on Jurkat cells were visualized on RS-100 imager by using 365 nm
LED and a 420 nm high band-pass filter for Hoechst 33342 and 530 nm LED and a
590 nm high band-pass filter for PI. The regions with the high fluorescent signal from
Hoechst 33342 were defined as nuclei. The cells whose nucleus was stained with both
Hoechst and PI were regarded as dead cells and excluded from the quantification. The
fluorescent signals of PI in the areas 14 pixels within the nuclear envelope excluding
the nuclei were regarded as the RNAs bound to a cell. The fluorescent signal was
normalized by the number of the base pairs of the indicated Tri-RNA in order to
obtain the relative number of RNA on a cell surface. To calculate the mean amount of
RNA on cell surface, 100-3,000 cells were analyzed in each sample.
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